HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yunqi Han Selected Research

Phosphotransferases (Kinase)

1/2017CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yunqi Han Research Topics

Disease

1Polyploidy
10/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017

Drug/Important Bio-Agent (IBA)

1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2022
1AntioxidantsIBA
10/2022
1GibberellinsIBA
10/2022
1SaltsIBA
10/2022
1jasmonic acid (jasmonate)IBA
10/2022
1Plant Growth Regulators (Plant Hormones)IBA
10/2022
1Phosphotransferases (Kinase)IBA
01/2017